0001209191-20-052724.txt : 20201001
0001209191-20-052724.hdr.sgml : 20201001
20201001183822
ACCESSION NUMBER: 0001209191-20-052724
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201001
FILED AS OF DATE: 20201001
DATE AS OF CHANGE: 20201001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glickman Richard M
CENTRAL INDEX KEY: 0001352637
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37410
FILM NUMBER: 201217475
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ESSA Pharma Inc.
CENTRAL INDEX KEY: 0001633932
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
BUSINESS PHONE: (778) 331-0962
MAIL ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-01
0
0001633932
ESSA Pharma Inc.
EPIX
0001352637
Glickman Richard M
C/O ESSA PHARMA INC.
999 WEST BROADWAY, SUITE 720
VANCOUVER
A1
V5Z 1K5
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
38750
D
Options
4.90
2022-03-21
2028-02-21
Common Shares
8250
D
Options
4.90
2022-03-21
2024-05-21
Common Shares
3750
D
Options
3.81
2023-03-08
2029-02-08
Common Shares
10000
D
Options
3.23
2023-11-04
2029-10-04
Common Shares
30000
D
Options
4.67
2022-11-30
2029-10-30
Common Shares
25000
D
/s/ Richard Glickman
2020-10-01